Literature DB >> 15589829

Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.

Michaela A E Arndt1, Jürgen Krauss, Susanna M Rybak.   

Abstract

By varying linker length and domain orientation three multivalent derivatives of a monovalent anti-CD22 single-chain fragment variable (scFv) antibody were generated. Shortening the linker of the V(H)-V(L) oriented scFv to 5 or 0 residues resulted in the formation of diabodies or a mixture of tetramers and trimers, respectively. Unexpectedly, a V(L)-0-V(H) scFv assembled to homogenous dimers, remained substantially more stable than the V(H)-5-V(L) diabody when incubated in human serum at 37 degrees C, and retained its dimeric state when concentrated up to 4 mg/ml. These properties suggest the V(L)-0-V(H) scFv could become an attractive vehicle for the selective delivery of multiple effector molecules to CD22(+) tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589829     DOI: 10.1016/j.febslet.2004.11.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Oligomeric forms of single chain immunoglobulin (scIgG).

Authors:  Thomas Schirrmann; Christian Menzel; Michael Hust; Jessica Prilop; Thomas Jostock; Stefan Dübel
Journal:  MAbs       Date:  2010-01-26       Impact factor: 5.857

3.  Construction of non-covalent single-chain Fv dimers for hepatocellular carcinoma and their biological functions.

Authors:  Cai-Qun Bie; Dong-Hua Yang; Xu-Jing Liang; Shao-Hui Tang
Journal:  World J Hepatol       Date:  2010-05-27

4.  Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Authors:  Jeffrey V Leyton; Tove Olafsen; Mark A Sherman; Karl B Bauer; Patrick Aghajanian; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2008-10-28       Impact factor: 1.650

5.  ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

Authors:  Tove Olafsen; Shannon J Sirk; David J Betting; Vania E Kenanova; Karl B Bauer; Waldemar Ladno; Andrew A Raubitschek; John M Timmerman; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2010-01-06       Impact factor: 1.650

6.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

7.  Therapeutic potential of an anti-HER2 single chain antibody-DM1 conjugates for the treatment of HER2-positive cancer.

Authors:  Hang Zhang; Yuxi Wang; Yangping Wu; Xiaohua Jiang; Yiran Tao; Yuqin Yao; Yujia Peng; Xiangzheng Chen; Yuyin Fu; Lin Yu; Ruixue Wang; Qinhuai Lai; Weirong Lai; Wenting Li; Yuhuan Kang; Shuli Yi; Ying Lu; Lantu Gou; Min Wu; Jinliang Yang
Journal:  Signal Transduct Target Ther       Date:  2017-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.